Y-mAbs Therapeutics (YMAB) Earnings Date, Estimates & Call Transcripts

$15.34
+0.18 (+1.19%)
(As of 04/23/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 13Estimated
Actual EPS
(Feb. 29)
-$0.02 Beat By $0.17
Consensus EPS
(Feb. 29)
-$0.19
Skip Charts & View Estimated and Actual Earnings Data

YMAB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

YMAB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Y-mAbs Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($0.22)($0.11)($0.17) 
Q2 20242($0.23)($0.11)($0.17) 
Q3 20242($0.20)($0.12)($0.16) 
Q4 20242($0.19)($0.12)($0.16) 
FY 20248($0.84)($0.46)($0.65) 
Q1 20251($0.11)($0.11)($0.11) 
Q2 20251($0.10)($0.10)($0.10) 
Q3 20251($0.11)($0.11)($0.11) 
Q4 20251($0.14)($0.14)($0.14) 
FY 20254($0.46)($0.46) ($0.46)

YMAB Earnings Date and Information

Y-mAbs Therapeutics last announced its earnings results on February 29th, 2024. The reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.19) by $0.17. The firm had revenue of $23.36 million for the quarter, compared to analyst estimates of $21.72 million. Y-mAbs Therapeutics has generated ($0.49) earnings per share over the last year (($0.49) diluted earnings per share). Earnings for Y-mAbs Therapeutics are expected to grow in the coming year, from ($0.43) to ($0.29) per share. Y-mAbs Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

Y-mAbs Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)
------- 
2/29/2024Q4 2023($0.19)($0.02)+$0.17($0.02)$21.72 million$23.36 million
11/13/2023Q3 2023($0.16)($0.18)($0.02)($0.18)$20.56 million$20.45 million
8/10/2023Q2 2023($0.24)($0.14)+$0.10($0.14)$19.04 million$20.75 million
5/8/2023Q1 2023($0.31)($0.15)+$0.16($0.15)$15.55 million$20.30 million    
3/31/2023Q4 2022($0.44)$0.03+$0.47$0.03$20.35 million$31.45 million    
11/7/2022Q3 2022($0.75)($0.63)+$0.12($0.63)$11.69 million$12.54 million    
8/8/2022Q2 2022($0.68)($0.94)($0.26)($0.94)$11.22 million$10.80 million    
5/9/2022Q1 2022($0.71)($0.64)+$0.07($0.64)$11.10 million$10.49 million    
2/24/2022Q4 2021($0.71)($0.85)($0.14)($0.85)$10.82 million$9.60 million    
11/4/2021Q3 2021($0.58)($0.66)($0.08)($0.66)$10.87 million$8.97 million    
8/5/2021Q2 2021($0.68)($0.53)+$0.15($0.53)$7.66 million$10.95 million    
5/6/2021Q1 2021$0.61$0.75+$0.14$0.75$35.67 million$5.38 million  

Y-mAbs Therapeutics Earnings - Frequently Asked Questions

When is Y-mAbs Therapeutics's earnings date?

Y-mAbs Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on YMAB's earnings history.

Did Y-mAbs Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Y-mAbs Therapeutics (NASDAQ:YMAB) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.17. Learn more on analysts' earnings estimate vs. YMAB's actual earnings.

How much revenue does Y-mAbs Therapeutics generate each year?

Y-mAbs Therapeutics (NASDAQ:YMAB) has a recorded annual revenue of $84.82 million.

How much profit does Y-mAbs Therapeutics generate each year?

Y-mAbs Therapeutics (NASDAQ:YMAB) has a recorded net income of -$21.43 million. YMAB has generated -$0.49 earnings per share over the last four quarters.

What is Y-mAbs Therapeutics's EPS forecast for next year?

Y-mAbs Therapeutics's earnings are expected to grow from ($0.43) per share to ($0.29) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:YMAB) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners